AMBIOPHARM

Serial Number 76508884
606

Registration Progress

Application Filed
Apr 23, 2003
Under Examination
Oct 19, 2004
Approved for Publication
Jan 7, 2004
Published for Opposition
Jan 27, 2004
Registered

Trademark Image

AMBIOPHARM

Basic Information

Serial Number
76508884
Filing Date
April 23, 2003
Published for Opposition
January 27, 2004
Abandonment Date
October 20, 2005
Drawing Code
1000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Oct 20, 2005
Classes
005 042

Rights Holder

Ambiopharm, Inc.

03
Address
41 Shortland Street
P.O. Box 2165
Auckland
NZ

Ownership History

Ambiopharm, Inc.

Original Applicant
03
Auckland NZ

Ambiopharm, Inc.

Owner at Publication
03
Auckland NZ

Legal Representation

Attorney
Suzanne L. Glassburn

USPTO Deadlines

All Deadlines Cleared

All 3 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

15 events
Date Code Type Description Documents
Dec 21, 2005 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Dec 21, 2005 MAB6 O ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED Loading...
Apr 7, 2005 EX1G S SOU EXTENSION 1 GRANTED Loading...
Mar 8, 2005 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Mar 8, 2005 EXT1 S SOU EXTENSION 1 FILED Loading...
Oct 19, 2004 NOAM O NOA MAILED - SOU REQUIRED FROM APPLICANT Loading...
Sep 1, 2004 CFIT O CASE FILE IN TICRS Loading...
Aug 18, 2004 ETOP T EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED Loading...
Feb 23, 2004 ETOF T EXTENSION OF TIME TO OPPOSE RECEIVED Loading...
Jan 27, 2004 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jan 7, 2004 NPUB O NOTICE OF PUBLICATION Loading...
Dec 5, 2003 CNEA O EXAMINERS AMENDMENT MAILED Loading...
Dec 5, 2003 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Sep 16, 2003 CNRT F NON-FINAL ACTION MAILED Loading...
Sep 11, 2003 DOCK D ASSIGNED TO EXAMINER Loading...

Detailed Classifications

Class 005
pharmaceutical preparations for use in the treatment of diabetes mellitus, heart disease, kidney disease, liver disease, and fibril-medicated disease
First Use Anywhere: 0
First Use in Commerce: 0
Class 042
Laboratory research in the fields of proteomics, biochemistry, molecular biology, cell biology, and physiology; laboratory services in the nature of testing for new product identification and developments; quality control and testing of the development of pharmaceuticals and pharmaceutical candidates; scientific research; developing assays for the diagnosis of disease; developing chemical markers for disease states; laboratory research to determine targets for drugs and protein and peptide sequences; and development of proteomic and genomic research testing methods
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005 042